This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Regional Universitaire De Nancy, Universite Dé Lorraine. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 93 
Years Active: 2024
Title: Loïc Reppel: Innovator in Stem Cell Research
Introduction
Loïc Reppel is a notable inventor based in Nancy, France. He has made significant contributions to the field of stem cell research, particularly in the therapeutic applications of mesenchymal stem cells.
Latest Patents
Loïc Reppel holds a patent for "Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis." This patent relates to human mesenchymal stem cells derived from Wharton's jelly, detailing a method for their preparation and therapeutic uses, especially for treating sepsis and septic shock. The treatment involves administering a pharmaceutical composition that includes these stem cells and a pharmaceutically acceptable excipient.
Career Highlights
Throughout his career, Loïc Reppel has worked with esteemed institutions such as Université de Lorraine and Centre Hospitalier Régional Universitaire de Nancy. His work has focused on advancing the understanding and application of stem cell therapies.
Collaborations
Loïc has collaborated with notable colleagues, including Danièle Bensoussan and Sébastien Gibot, contributing to the advancement of research in his field.
Conclusion
Loïc Reppel's innovative work in stem cell research, particularly his patent on mesenchymal stem cells, showcases his commitment to advancing medical treatments for critical conditions like sepsis. His contributions are paving the way for future developments in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile